Foresee Prescribed drugs Proclaims Preliminary Outcomes from a Part 1 Scientific Trial, Highlighting Promising Security, Tolerability and Pharmacokinetic Profile of Linvemastat (FP-020), a Novel and Choose By Investing.com
TAIPEI, Oct. 20, 2024 /PRNewswire/ -- Foresee Prescribed drugs (TPEx: 6576), ("Foresee")…
